Skip to content
Wired News Engine – Lifestyle
Author:
Cumulus Neuroscience
NeuLogiq® Platform Helps Confirm No Evidence of Psychotomimetic, Hallucinatory, or Dissociative Effects in a Phase 1b Study of a Novel Neuroplastogen Developed for Major Depressive Disorder
May 28, 2026